Venetoclax-Targeted Therapy in t(11;14) AL Amyloidosis Patients after Frontline Daratumumab and Cybord: A Retrospective Analysis from the French Amyloidosis NetworkMurielle Roussel, Arnaud Jaccard, Michelle Pirotte et al.|Blood|2022Cited by 3
Efficacy and Safety of Isatuximab, Pomalidomide and Dexamethasone in Relapsed AL Amyloidosis: Interim Results of the Isamyp Phase 2 Joint Study from the IFM and ALLGPeter Mollee, Murielle Roussel, Cécile Leyronnas et al.|Blood|2024Cited by 3